Tackling unmet needs in lymphoma
Why we need novel strategies for diffuse large B-cell lymphoma
Treatment at first relapse in multiple myeloma: how to choose a drug?
Impact of somatic gene mutations on response to lenalidomide in MDS patients
Biosimilars for treating follicular lymphoma – update on clinical trials